January 1, 2012Thrombosis and Haemostasis

Clinical scores to predict recurrence risk of venous thromboembolism

View Full Paper

Ask AI

Bookmark

Why the study?

Can clinical scoring models accurately predict the risk of recurrent VTE to guide the duration of anticoagulation therapy in patients with unprovoked VTE?

Population

Patients with unprovoked venous thromboembolism (VTE)

Design

Review

Authors

SESabine EichingerVascular Medicine PKPaul A. KyrleVascular / Pulmonary Vascular

Discussion

Member takes

Implication

Should not yet guide anticoagulation duration in unprovoked VTE; leaves open utility after prospective validation.

Structured PICO

Can clinical scoring models accurately predict the risk of recurrent VTE to guide the duration of anticoagulation therapy in patients with unprovoked VTE?

Population

Patients with unprovoked venous thromboembolism (VTE)

Intervention

Clinical scoring models linking clinical patient characteristics with laboratory testing to assess the risk of recurrent VTE

Outcome

Risk of recurrent VTE

Clinical scoring systems offer a novel approach to stratify recurrent VTE risk and guide anticoagulation duration, though prospective validation is needed.

Cite This Study

Eichinger et al. (2012) studied this question.

synapsesocial.com/papers/6a7fd81744653b9d99152f47 https://doi.org/10.1160/th12-05-0353

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Clinical scores to predict recurrence risk of venous thromboembolism

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Clinical scores to predict recurrence risk of venous thromboembolism

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider